publication date: Dec. 19, 2010

In this issue: 

Charles Balch resigns as ASCO executive vice president; Joseph Bailes named interim EVP.

Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.

Senate approves NIH funding bill. NCI awards $25 million to eight institutions for patient navigator programs; $35 million awarded for nanotechnology partnerships.

NIH-funded HapMap consortium publishes first phase of catalog.

NIH begins transition to electronic grant submissions; seeks comment on options for NRSA funding.

Download (PDF 775KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.